4.7 Article

Effects of a Tailored Text Messaging Intervention Among Diverse Adults With Type 2 Diabetes: Evidence From the 15-Month REACH Randomized Controlled Trial

Journal

DIABETES CARE
Volume 44, Issue 1, Pages 26-34

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc20-0961

Keywords

-

Funding

  1. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK-100694]
  2. Vanderbilt Center for Diabetes Translation Research [P30-DK-092986]
  3. NIH National Institute of Diabetes and Digestive and Kidney Diseases [K01-DK-106306]
  4. NIH National Heart, Lung, and Blood Institute [K12-HL-137943]

Ask authors/readers for more resources

Text messaging interventions have high potential for reducing health disparities and improving short-term outcomes in diabetes management, but may not be sufficient for sustained long-term effects. More rigorous, long-term trials are needed to further examine the efficacy and mechanisms of such interventions.
OBJECTIVE Text messaging interventions have high potential for scalability and for reductions in health disparities. However, more rigorous, long-term trials are needed. We examined the long-term efficacy and mechanisms of a tailored text messaging intervention. RESEARCH DESIGN AND METHODS Adults with type 2 diabetes participated in a parallel-groups, 15-month randomized controlled trial and were assigned to receive Rapid Education/Encouragement and Communications for Health (REACH) for 12 months or control. REACH included interactive texts and tailored texts addressing medication adherence and nontailored texts supporting other self-care behaviors. Outcomes included hemoglobin A(1c) (HbA(1c)), diabetes medication adherence, self-care, and self-efficacy. RESULTS Participants (N = 506) were approximately half racial/ethnic minorities, and half were underinsured, had annual household incomes <$35,000, and had a high school education or less; 11% were homeless. Average baseline HbA(1c) was 8.6% +/- 1.8%; 70.0 +/- 19.7 mmol/mol) with n = 219 having HbA(1c) >= 8.5% (69 mmol/mol). Half were prescribed insulin. Retention was over 90%. Median response rate to interactive texts was 91% (interquartile range 75%, 97%). The treatment effect on HbA(1c) at 6 months (-0.31%; 95% CI -0.61%, -0.02%) was greater among those with baseline HbA(1c) >= 8.5% (-0.74%; 95% CI -1.26%, -0.23%), and there was no evidence of effect modification by race/ethnicity or socioeconomic disadvantage. REACH improved medication adherence and diet through 12 months and self-efficacy through 6 months. Treatment effects were not significant for any outcome at 15 months. REACH reduced barriers to adherence, but barrier reduction did not mediate outcome improvements. CONCLUSIONS REACH engaged at-risk patients in diabetes self-management and improved short-term HbA(1c). More than texts alone may be needed to sustain the effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available